| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/2009 | CN100478355C New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
| 04/15/2009 | CN100478354C Novel human protein with cancer inhibiting function and its code sequence |
| 04/15/2009 | CN100478353C Polyacrylamide gel electrophoresis method for wheat low molecular weight glutenin subunit |
| 04/15/2009 | CN100478352C Hapten-marked peptides |
| 04/14/2009 | US7518042 Plants and seeds of corn variety I428355 |
| 04/14/2009 | US7518041 Plants and seeds of corn variety I932310 |
| 04/14/2009 | US7518035 Promoter molecules for use in plants |
| 04/14/2009 | US7518034 polynucleotides that encode plant transcription factors; using such constructs in modulating the expression of endogenous and/or heterologous genes; transgenic plants; modifying plant phenotypes |
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517973 Expression vector comprising nucleotide sequences coding astrocyte enhanced/suppressed gene sequences for use as tool in identifying modulators for treatment and prevention of viral-related nervous system disorders |
| 04/14/2009 | US7517972 Nucleic acid sequences encoding a bitter taste receptor, T2R76 |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517968 Using citric acid precipitation to isolate g protein coupled receptor protein |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517966 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for medical diagnosis, prevention of viral and microbial infections, and as antitumor agents |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517961 Homogeneous preparations of IL-28 and IL-29 |
| 04/14/2009 | US7517960 comprising polypeptides, fusion proteins, dimers and tetramers, useful for identification and development of activators and inhibitors for treating nervous system disorders |
| 04/14/2009 | US7517959 suppressor of cytokine signalling 3 (SOCS3) proteins, which has a deletion/inactivation aof the proline-, glutamic acid-, serine- and threonine-rich (PEST) domain peptide; inhibitors of leukemia-inhibitory factor-induced signal transducer and activator of transcription activity; gene and protein therapy |
| 04/14/2009 | US7517958 Interleukin-17 receptor homologue |
| 04/14/2009 | US7517957 Human SLAP-2: a novel SH2/ SH3 domain-containing human SLAP homologue having immune cell-specific expression |
| 04/14/2009 | US7517956 insecticidal proteins isolated from gramnegative bacteria, used for controlling insects |
| 04/14/2009 | US7517955 Lactoferrin binding protein for use in diagnosis, treatment and prevention of streptococcal pathogen infection |
| 04/14/2009 | US7517954 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 04/14/2009 | US7517953 With low peroxide and anisidine values and high polyunsaturated fatty acid content; heating from 40 to 70 degrees C at a rate of 1 degree per minute, a plateau stage, cooling at the same rate; improved electrical efficency; baby formula |
| 04/14/2009 | US7517952 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/14/2009 | US7517950 polypeptide that binds to major histocompatibility complex (MHC) proteins and induces cytotoxic t lymphocytes when bound to MHC antigens; anticancer vaccines |
| 04/14/2009 | US7517949 Livin-derived peptides, compositions and uses thereof |
| 04/14/2009 | US7517948 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517863 Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517856 Bioactive polypeptide conjugated to the sulfate group; sustained release; anticancer; alginate sulfate or sulfated hyaluronan conjugated to e.g. insulin, glatiramer acetate, antithrombin III, interferon gamma , IGF, somatostatin, luteinizing hormone-releasing hormone, erythropoietin, interleukins |
| 04/14/2009 | US7517854 Melanocortin receptor agonists |
| 04/14/2009 | US7517853 Biodrugs for treatment of neoplasia and acromegaly |
| 04/14/2009 | US7517849 ATP-binding cassette transporter protein-inhibiting peptide; impair the functioning of the ABC transporter responsible for conferring resistance to chemotherapeutic agents cancer cells, rendering them more susceptible to killing by standard chemotherapeutic agents; 1st peptide end negatively charged |
| 04/14/2009 | US7517685 of tolyplocladium comprising a nucleotide sequence capable of controlling expression of a gene when in a fungal species and coding for proteins having hydrolase enzyme activity, antibodies, growth factors, growth inhibitors and tissue activators |
| 04/14/2009 | US7517684 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 04/14/2009 | US7517683 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517669 Increasing the intracellular amount of at least one ferritin-H or a derivative to an effective level for suppressing disease caused or enhanced by effects of intracellular iron mismanagement |
| 04/14/2009 | US7517666 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517659 Comprises nucleotide sequences coding tandem of P domains in a weak inward rectifying potassium channel (TWIK) for identifying modulators and treatment of pain and headache disorders |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517655 Protein capable of deposition onto extracellular matrix |
| 04/14/2009 | US7517652 Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3 |
| 04/14/2009 | US7517649 Contacting a sample with a nucleic acid molecule encoding OGFr and determining the level of the mRNA encoding said OGFr; antisense molecules, expression vectors and host cells, and proteins; anticarcinogenic and wound healing agents; drug screening |
| 04/14/2009 | US7517648 NPHP nucleic acids and proteins |
| 04/14/2009 | US7517533 Pseudomonas aeruginosa antigens |
| 04/14/2009 | US7517530 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | US7517524 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | US7517520 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 04/14/2009 | CA2304980C Immunoassay to detect herpesvirus specific igm |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 04/14/2009 | CA2201887C Patched genes and their use |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/14/2009 | CA1341592C Ion capture reagents and methods for performing binding assays |
| 04/09/2009 | WO2009046464A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | WO2009046453A2 Use of neuregulin-1 in reducing brain damage |
| 04/09/2009 | WO2009046080A1 N-terminal modified interferon-alpha |
| 04/09/2009 | WO2009046015A2 Combination therapies for treating type 1 diabetes |
| 04/09/2009 | WO2009045632A2 Nucleic acid based fluorescent sensor for mercury detection |
| 04/09/2009 | WO2009045617A1 Porcine umami taste receptors and uses therefor |
| 04/09/2009 | WO2009045596A2 Optimized dengue virus entry inhibitory peptide (10an) |
| 04/09/2009 | WO2009045550A2 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/09/2009 | WO2009045508A1 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 04/09/2009 | WO2009045377A2 A non-desensitizing mutant of the transient receptor potential trpm5 ion channel |
| 04/09/2009 | WO2009044918A1 Neuromedin u derivative |
| 04/09/2009 | WO2009044787A1 Remedy for tendon rupture disease comprising tenomodulin as the active ingredient |
| 04/09/2009 | WO2009044722A1 Gene susceptible to disease associated with intervertebral disc degeneration and use thereof |
| 04/09/2009 | WO2009044650A1 Labeled peptide having activity of binding to immunoglobulin and/or immunoglobulin complex and method of detecting or assaying immunoglobulin by using the peptide |
| 04/09/2009 | WO2009044561A1 ANTI-proNT/NMN MONOCLONAL ANTIBODY |
| 04/09/2009 | WO2009044383A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof |
| 04/09/2009 | WO2009044284A1 Antibodies specific for human hepcidin |
| 04/09/2009 | WO2009044279A2 Peptides having antimicrobial and/or biosurfactant properties |
| 04/09/2009 | WO2009044173A2 Methods of treating cancer using notch pathway inhibitors |
| 04/09/2009 | WO2009044158A2 Inhibitors and uses |
| 04/09/2009 | WO2009044153A2 Inhibitors and uses |
| 04/09/2009 | WO2009043963A1 Use of the sequence encoding the carboxyl-terminal domain of the heavy chain of tetanus toxin as a drug |
| 04/09/2009 | WO2009043953A1 Use of truncated ppar-alpha inhibitors in the treatment of heart failure in patients with hypertensive cardiopathy |
| 04/09/2009 | WO2009043940A2 Peptides with high affinity for the prolactin receptor |
| 04/09/2009 | WO2009043908A2 Novel marker genes for regulatory t cells from human blood |
| 04/09/2009 | WO2009043900A1 Drug transfer based on coenzyme a and acyl carrier protein |
| 04/09/2009 | WO2009043858A2 Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease |
| 04/09/2009 | WO2009043173A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | WO2009043163A1 Bacterial degradation of paralytic shellfish toxins |
| 04/09/2009 | WO2009026465A3 Composition and methods of making and using influenza proteins |
| 04/09/2009 | WO2009023164A3 Induction of mucosal immunity |
| 04/09/2009 | WO2009022235A3 Variants of prolactin as antagonists of its receptor |
| 04/09/2009 | WO2009020559A3 Agents that inhibit p-tefb interactions and methods of use thereof |
| 04/09/2009 | WO2009020553A3 Chlamydia antigens |
| 04/09/2009 | WO2009016384A3 Gsk-3 inhibitors |
| 04/09/2009 | WO2009015283A3 Bhc80 - histone complexes and uses thereof |
| 04/09/2009 | WO2009010460A3 Transgenic plants with increased stress tolerance and yield |
| 04/09/2009 | WO2009008921A3 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors |